Navigation Links
Inovio Pharmaceuticals to Present at Biotech Showcase 2014 Investor Conference
Date:1/6/2014

BLUE BELL, Pa., Jan. 6, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) announced today that Dr. J. Joseph Kim, President and CEO, will present a corporate overview of the company at the Biotech Showcase 2014 investor conference in San Francisco, CA.

Biotech Showcase 2014

January 13-15
Parc55 Hotel
San Francisco, CA

Inovio Presentation
Monday, January 13
3:30 PM PT

A live webcast of Dr. Kim's Biotech Showcase presentation can be accessed at the following URL: http://www.media-server.com/m/p/d9hvz9mo. An archived version of the webcast will be available two hours following the presentation and can be accessed on the homepage of Inovio's website under the webcast tab at www.inovio.com.

About Inovio Pharmaceuticals, Inc.

Inovio is revolutionizing vaccines to prevent and treat today's cancers and challenging infectious diseases. Its SynCon® vaccines, in combination with its proprietary electroporation delivery, are generating best-in-class immune responses, with therapeutic T-cell responses exceeding other technologies in terms of magnitude, breadth, and response rate. Human data to date have shown a favorable safety profile. Inovio's lead vaccine, a therapeutic against HPV-caused pre-cancers and cancers, is in phase II. Other phase I and preclinical programs target prostate, breast, and lung cancers as well as HIV, influenza, malaria and hepatitis. Partners and collaborators include Roche, the University of Pennsylvania, Merck, NIH, HIV Vaccines Trial Network, National Cancer Institute, U.S. Military HIV Research Program, University of Southampton, US Dept. of Homeland Security, University of Manitoba and PATH Malaria Vaccine Initiative. More information is available at '/>"/>

SOURCE Inovio Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Inovio Pharmaceuticals Granted U.S. Patent Protection for Synthetic Vaccine for Cervical Dysplasia and Cancer
2. Inovio Pharmaceuticals Reports 2012 First Quarter Financial Results
3. Inovio Pharmaceuticals to Present at SPI 2012
4. Inovio Pharmaceuticals Universal Avian Flu Vaccine Generates Protective Antibody Responses Against Six H5N1 Viruses in Phase I Trial
5. Inovio Pharmaceuticals to Present at JMP Investor Conference
6. Inovio Initiates H1N1 Universal Influenza Vaccine Clinical Trial Targeting Over-65 Population, Which Represents 90% of Flu Deaths
7. Inovio Pharmaceuticals Inc. to Webcast, Live, at RetailInvestorConferences.com on August 2nd
8. Inovio Pharmaceuticals Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
9. Inovio Pharmaceuticals Reports 2012 Second Quarter Financial Results
10. Inovio Pharmaceuticals Takes Major Stride Toward Universal Influenza Vaccine
11. Inovio Pharmaceuticals Reports 2012 Third Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... , July 10, 2014   LabStyle Innovations ... Solution, today announced the appointment of Professor ... of its Board of Directors. Prof. ... business experience to LabStyle as an entrepreneur, venture ... and corporate governance expert. He currently serves on ...
(Date:1/15/2014)... , Jan. 15, 2014 Most osteoporosis patients want ... a recent online survey* sponsored by Mission Pharmacal Company. ... National Osteoporosis Foundation online support community, revealed that 74 ... that comes in a form other than a pill ...
(Date:1/15/2014)... Jan. 15, 2014  Celsion Corporation (the "Company") (NASDAQ: ... from institutional investors to purchase an aggregate of approximately ... at-the-market registered direct offering, led by a dedicated health ... purchase agreements with these investors pursuant to which the ...
Breaking Medicine Technology:LabStyle Innovations Welcomes Richard B. Stone to its Board of Directors 2LabStyle Innovations Welcomes Richard B. Stone to its Board of Directors 3LabStyle Innovations Welcomes Richard B. Stone to its Board of Directors 4Mission Pharmacal Conducts Online Survey of Osteoporosis Patients 2Mission Pharmacal Conducts Online Survey of Osteoporosis Patients 3Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 2Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 3
... --  Empire Genomics today announced that it has ... portfolio for the Japanese market.  The deal represents Empire,s international ... "We are excited to have such a proven and expert ... access to our broad genomic product and service portfolio," said ...
... MYL ) today announced that its subsidiary Mylan Pharmaceuticals Inc. ... Administration (FDA) for its Abbreviated New Drug Application (ANDA) for ... mg, 15 mg, and 20 mg. This product is the ... which is indicated for the treatment of schizophrenia and the ...
Cached Medicine Technology:Empire Genomics Chooses Funakoshi as Japan Distributor 2Mylan Launches Generic Version of Zyprexa® Tablets 2
(Date:7/10/2014)... 10, 2014 (HealthDay News) -- Most professional football players ... to the game, a new study finds. Shoulder ... their rate of return after surgery to fix the ... The new study included 60 players who had shoulder ... procedure successfully returned to play, defined as playing in ...
(Date:7/10/2014)... HealthDay Reporter THURSDAY, July 10, 2014 ... out regularly between outspoken celebrities or loudmouth pundits -- too ... new study suggests. High amounts of Twitter use can ... is in a long-term relationship, according to findings from an ... friction can lead to cheating and breakups, the researchers concluded, ...
(Date:7/10/2014)... a microchip-based device developed at the Massachusetts General Hospital ... Cancer Center can be cultured to establish cell lines ... July 11 issue of Science , an MGH ... a tumor,s genetic mutation over time and changing susceptibility ... cells from the blood that represent those present in ...
(Date:7/10/2014)... EAST LANSING, Mich. For those students looking to ... answer may not be spending more time in a ... New Michigan State University research shows that students who ... on MSU,s campus during their freshman and sophomore years ... The research also indicated that students with memberships stayed ...
(Date:7/10/2014)... 2014) A research review identifying the clinical indicators ... step in the process of developing evidence-based guidelines for ... report published by Neurosurgery , official ... . The journal is published by Lippincott Williams ... Kluwer Health . , Based on analysis of ...
Breaking Medicine News(10 mins):Health News:Shoulder Surgery Gets NFL Players Back in the Game 2Health News:Are You Tweeting Your Marriage Away? 2Health News:Are You Tweeting Your Marriage Away? 3Health News:Cultured CTCs reveal genetic profile, potential drug susceptibility of breast cancer cells 2Health News:Cultured CTCs reveal genetic profile, potential drug susceptibility of breast cancer cells 3Health News:Want a higher GPA in college? Join a gym 2Health News:What's a concussion? Review identifies four evidence-based indicators 2Health News:What's a concussion? Review identifies four evidence-based indicators 3
... of Pennsylvania School of Medicine and Utrecht University has deciphered ... immune response. This system, called complement, comprises a network of ... invaders. It serves as a rapid defense mechanism in most ... published in the December 24 issue of Science , ...
... Reporter , MONDAY, Dec. 27 (HealthDay News) -- Marilyn Norred has ... "They saw them back then and said, ,Someday they,ll be ... in Oklahoma City, recalled. That time came this year. Norred ... right eye on May 27 and the left eye on June ...
... FRIDAY, Dec. 24 (HealthDay News) -- For years now, doctors ... a chronic autoimmune condition that can wrack the body and ... preparing for a potential major leap forward. A ... the disease was endorsed in mid-November by an advisory panel ...
... HealthDay Reporter , FRIDAY, Dec. 24 (HealthDay News) -- ... 1999. "I would wake up very stiff and achy," said ... a while to get going in the morning." Then, after ... woke up one morning and it was like I was paralyzed," ...
... Reporter , THURSDAY, Dec. 23 (HealthDay News) -- Cynthia Duggan ... needed dental braces that she hesitated to give her veterinarian ... procedure with her husband, the couple finally decided it would ... Duggan of the 9-month-old puppy, already showing potential as a ...
... , THURSDAY, Dec. 23 (HealthDay News) -- Hospital-wide patient death ... facility,s quality of care, a new study indicates. Researchers ... They found that the measures yielded both higher- and lower-than-expected ... The findings add to an ongoing debate about the ...
Cached Medicine News:Health News:Structure of key molecule in immune system provides clues for designing drugs 2Health News:Structure of key molecule in immune system provides clues for designing drugs 3Health News:Have Cataracts? Get Surgery, Woman Urges 2Health News:Lupus Treatment May Soon Take Leap Forward 2Health News:Lupus Treatment May Soon Take Leap Forward 3Health News:For California Woman, Lupus Is Life 2Health News:Doggy Dentistry Can Now Mean Braces 2Health News:Doggy Dentistry Can Now Mean Braces 3Health News:Better Methods Needed to Measure Hospital Quality: Experts 2
... SPECIFICATIONS Form: Granular, free-flowing powder EEO (-m r ): ... less than or equal to 35C Remelt Point (3%): ... greater than or equal to 300 gm/cm 2 ... than or equal to 0.10% DNase: Passes test RNase: ...
... sulfate (SO 4 ) ≤ 1000 mg/kg Cation traces: ... ≤ 5 mg/kg Cr ≤ 5 mg/kg Cu ≤ ... mg/kg Mg ≤ 50 mg/kg Mn ≤ 5 mg/kg ... ≤ 5 mg/kg Zn ≤ 5 mg/kg Special grade: ...
... ≤ 500 mg/kg sulfate (SO 4 ) ≤ 1000 ... 5 mg/kg Co ≤ 5 mg/kg Cr ≤ 10 ... K ≤ 5 mg/kg Mg ≤ 5 mg/kg Mn ... 5 mg/kg Pb ≤ 5 mg/kg Zn ≤ 5 ...
Inquire...
Medicine Products: